ShengYu Ku

Research Fellow @DanaFarber Prostate Cancer Foundation Young Investigator @PCF_Science.

[ShengYu Ku @ShengyuKu]

Congratulations 👏👏to our very own Dr Beltran @mishabeltran and the team @sands_jacob @Andres_M_Acosta awarded a prestigious PCF Challenge to develop new immune therapies for pts with NEPC. We commit to #CureCancer

@DanaFarber @DanaFarber_GU @PCF_Science

[Prostate Cancer Foundation @PCFnews]

We're excited to announce the 2022 Class of PCF Team Challenge Award recipients and a total of more than $12 million in funding for innovative prostate cancer research.

Press release - https://t.co/KiACAhBwhX
Projects- https://t.co/n7Zc5edztZ

[ShengYu Ku @ShengyuKu]

@WCMEnglanderIPM @RickmanLab @theNCI Congratulation to David @RickmanLab ! It's Awesome!

[ShengYu Ku @ShengyuKu]

@PellegrinoMD @SimoneScuderi1 @GGandaglia @GFallara_MD @LeniRiccardo @ArmandoStabile @elio_mazzone Congratulations Antony! Super Star!

[Bhavneet Bhinder @BhavneetBhinder]

How does the immune landscape of NEPC differ from primary/met prostate adenocarcinomas & SCLC? We explore these questions in our recent work collab ⁦@mishabeltran⁩ ⁦@ElementoLab⁩ ⁦@WCMEnglanderIPM⁩ & published in ⁦@AACR⁩ ⁦⁩
https://t.co/XkokWBFTxA

[ShengYu Ku @ShengyuKu]

Full text: https://t.co/wzpQCKqRqg

[ShengYu Ku @ShengyuKu]

Congratulations to our very own @mishabeltran collab with @BhavneetBhinder @ElementoLab published a new study to reveal immune landscape of NEPC

@DanaFarber_GU @PCF_Science #WomenInScience

The Immunogenomic Landscape of Neuroendocrine Prostate Cancer https://t.co/3PSl4DePJU

[Prostate Cancer @CaP_pubs]

The Immunogenomic Landscape of Neuroendocrine Prostate Cancer. 𝘾𝙡𝙞𝙣 𝘾𝙖𝙣𝙘𝙚𝙧 𝙍𝙚𝙨.

@mishabeltran

#ProstateCancer

https://t.co/fMJTUFSfyu

[Dana-Farber Lank Center for Genitourinary Oncology @DanaFarber_GU]

We are thrilled to see a wonderful profile of the Lank Center's own Dr. Mary-Ellen Taplin in the journal @JournalCancer this morning! A great, quick read on her career, mentorship, and impact to start your week off with some inspiration 👇

https://t.co/qkyJLLYlLB

[ShengYu Ku @ShengyuKu]

@InscoLab Congratulations to Tanzina and Megan! Great mentorship!

[ShengYu Ku @ShengyuKu]

@PellegrinoMD @IntuitiveSurg @SimoneCrivella2 Congratulations man! Must be a stellar talk 👏

[ShengYu Ku @ShengyuKu]

@InscoLab @leonard_zon @youngricka @AdelmanLab @NCIChanock @kbrowngenetics @TheAbraLab @dliu_ccb @bmart87 Congratulations Megan 🍾
Look forward to reading !

[Insco Lab @InscoLab]

Excited to share this tremendous team’s work on CDK13! Thanks to everyone who made this possible! @leonard_zon, Paul Boutz, Phil Sharp, @youngricka, @AdelmanLab, Matthias Geyer, @NCIChanock, @kbrowngenetics, @TheAbraLab, @dliu_ccb, @bmart87, Tongwu Zhang

https://t.co/RU3D4bJwR2

[ShengYu Ku @ShengyuKu]

@HsiehLab @SujataJanaPhD @fredhutch @Cancer_Cell @DrawImpacts @PGrivasMDPhD @FaltasLab @BladderCancerUS @UrologySBUR @urotoday @gulleyj1 @NCICancerBio @DavidDeGraff5 @WilliamKimMD To bad! It’s really a nice image. Thanks for sharing it!

[Nature Cancer @NatureCancer]

💫ONLINE NOW @NatureCancer “Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer” by @mishabeltran @mkbakht & Co.
@NatResCancer

Read it here👇
https://t.co/xrn1NekyVD
https://t.co/Nmu0c54fjm

[ShengYu Ku @ShengyuKu]

@jklee_lab @NatureComms @vipulbhatia24 @BioengIshihara @SaulPriceman @sriv4000 @fredhutch @Prostate_IPCR @PCF_Science Congrats John and the team🍾

[Toni Choueiri, MD @DrChoueiri]

Outstanding work from @mishabeltran Lab and colleagues in @NatureCancer==> "Landscape of Prostate-Specific Membrane Antigen Heterogeneity and Regulation in AR-positive and AR-negative Metastatic Prostate Cancer"

https://t.co/Fj31BHlFa7

@DanaFarber_GU @DanaFarber @OncoAlert

[Dana-Farber News @DanaFarberNews]

New research in @NatureCancer reveals HOXB13 protein as key regulator of PSMA in #ProstateCancer and demonstrates PSMA control is complex.
Read more ➡️ https://t.co/huXBwM8woU

CC: @mishabeltran @DanaFarber_GU

[Misha Beltran @mishabeltran]

So excited to share our new paper @NatureCancer on PSMA regulation in AR-positive and AR-negative prostate cancer. Congratulations to lead author @mkbakht @DanaFarber We are grateful for many wonderful collaborators @DanaFarber_GU @PCF_Science
https://t.co/SwdSVhnAx3

[Sasha Gusev @SashaGusevPosts]

A 🧵 on study sections and grant review, the mechanism by which federal grants are evaluated and how many of us support our labs. A lot of opinions here so please yell at me where you disagree.

[ShengYu Ku @ShengyuKu]

@Bajji @mishabeltran @AACR Congratulations!!